10 Years Ago Peak Proteins Was Born
Our founder Mark Abbott takes us through the story of Peak Proteins. From the initial conception to the current status as part of Sygnature Discovery. We have grown steadily over the last 10 years and have assembled a large [...]
Contributing to the Development of New Anti-Thrombotic Biotherapeutics
Two Peak/Sygnature scientists, Juli Warwicker and Mark Abbott, have recently co-authored a paper on a new family of anti-thrombotic biotherapeutics. The paper is from the lab of Dr. Yotis Senis, Research Director, INSERM, Strasbourg, France. The Senis lab have [...]
Sygnature Discovery HPLC-FSEC / SEC-MALS Analytical Platform
We are delighted to announce that our new HPLC-FSEC / SEC-MALS platform is now up and running. We've chosen an Agilent BioInert HPLC system with a number of detectors, allowing us to monitor proteins by UV absorbance, fluorescence, and [...]
A Peak Inside Peak Proteins: Year 12 Students Come for a Site Visit for Some Career Inspiration
Last week a group of 15 sixth form students from All Hallows Catholic College came to visit Peak Proteins as part of their NCS (National Citizen Service) programme to help grow their employability skills. The afternoon was organised by [...]
Reflections on the Fidabio US User Group Meeting
At the recent FidaBio US User Group Meeting held in Boston, Duncan Smith was invited to give a talk highlighting how the Fida technology has had an impact on several of our recent drug discovery projects. For the last [...]
We welcome Rachel Johnson, another addition to our experienced Cryo-EM team
Sygnature Discovery is delighted to welcome Rachel Johnson to the Peak Proteins team. Rachel’s arrival highlights our commitment to offering our clients an exceptional Cryo-EM and structural biology service. Rachel has determined >20 cryo-EM structures of GPCRs allowing her [...]
IniXium and Peak Proteins – Stronger Together
As you will recall, Peak Proteins were acquired by Sygnature Discovery in April 2022. Now, that Sygnature have subsequently completed the acquisition of NuChem Sciences and their subsidiaries IniXium and OmegaChem in July this year, we are delighted to [...]
Peak Proteins Enters The ASM Agar Art Contest
In the spirit of International Microorganisms Day (17th September) we have been inspired to enter the highly competitive American Society for Microbiology agar art contest, this year based on the theme “Microbiology in Space”. With our site based in [...]
Celebrating The Peak Protein’s Team Reaching 50
It is 9 years since the formation of Peak Proteins and in July this year, with the arrival of Ariadna Juarez-Martinez, we reached 50 people. 50 people, all under one roof, all focused on protein science and structural biology [...]
SYGNATURE DISCOVERY ACCELERATES GLOBAL GROWTH WITH MAJOR NORTH AMERICAN ACQUISITION
Leading integrated drug discovery partner, Sygnature Discovery (“Sygnature”) has announced its acquisition of one of North America’s largest discovery Contract Research Organisations, Canada-based NuChem Sciences. This acquisition cements Sygnature as one of the world’s largest players in integrated drug [...]
Peak-ing the scientific interest of local students
At Peak Proteins we firmly believe in the transformative power of scientific education and inspiring young minds. While our primary role revolves around providing support for our client projects, we have also embarked on a journey of scientific outreach with [...]
We say goodbye to Hazel Weir
It is with a tear in the eye that we say a fond farewell to Hazel and wish her safe travels and a following wind with all her retirement plans and adventures. We cannot begin to pay tribute to all [...]
Peak Proteins Welcomes Valerie Pye
Peak Proteins is delighted to welcome Dr Valerie Pye as a Senior Principal Protein Crystallographer to the team. As an experienced protein structural biologist, Valerie has extensive knowledge and expertise in taking protein structure projects all the way from [...]
Rapid Assessment of Membrane Protein Quality by Fluorescent Size Exclusion Chromatography
Researchers from Peak Proteins (part of Sygnature Discovery Ltd.) have recently published a research paper in the Journal of Visualized Experiments. The paper entitled “Rapid Assessment of Membrane Protein Quality by Fluorescent Size Exclusion Chromatography” was authored by Dr [...]
Peak Proteins’ take on ‘A Christmas Carol’
by Head of BD, Hazel Weir. Thinking back on 2022 - a pretty momentous year for Peak Proteins (as well as the rest of the world!) - the story of Charles Dickens’ ‘A Christmas Carol’ came to mind – [...]
Margaret’s Christmas Cards
Christmas Congratulations to our artist-in-residence, Margaret Veldman-Jones, who recently raised over £400 for our nominated local charity, the East Cheshire Hospice, by selling her hand-designed Christmas to friends and colleagues. When she’s not dabbling in acrylics and paint, Margaret [...]
Inspiring the Next Generation of Scientists
Last week, one of our experienced graduate protein scientists, Naimah Begum, was asked to be a panellist at a plenary session held for over 200 students, organised by Manchester University’s Biological Science department. The aim of the plenary was [...]
We say goodbye to Amelia Tollet
As we say farewell to Amelia Tollet at the end of her three month summer internship at Peak Proteins, Hazel Weir, Director of BD, caught up with Amelia before she left to go back to Liverpool University for the [...]
Peak Proteins Adopts the Fida 1 Platform
We are delighted to announce we have recently acquired a new instrument and software, the Fida 1 platform…from FidaBio! Why Fidabio? We were looking to enhance the quality control (QC) package for proteins we were generating for clients and [...]
Advancing the Biophysical Characterisation of Membrane Protein Targets in Drug Discovery: a Sygnature Discovery, Peak Proteins and Cytiva Collaboration
We’re pleased to announce a new collaboration between protein scientists at Peak Proteins (now a Sygnature Company), members of the biophysics team at Sygnature Discovery, and surface plasmon resonance (SPR) experts at Cytiva to develop methods for membrane protein [...]
